Literature DB >> 30753420

Late onset heart failure after childhood chemotherapy.

Denise Hilfiker-Kleiner1, Hossein Ardehali2, Rodolphe Fischmeister3, Paul Burridge2, Emilio Hirsch4, Alexander R Lyon5,6.   

Abstract

Entities:  

Year:  2019        PMID： 30753420      PMCID： PMC6821336          DOI： 10.1093/eurheartj/ehz046

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

Review 1.  The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity.

Authors:  Huanrong Lan; Qi Xue; Yuyao Liu; Ketao Jin; Xingliang Fang; Hong Shao
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 5.249

Review 2.  Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.

Authors:  Tienush Rassaf; Matthias Totzeck; Johannes Backs; Carsten Bokemeyer; Michael Hallek; Denise Hilfiker-Kleiner; Andreas Hochhaus; Diana Lüftner; Oliver J Müller; Ulrich Neudorf; Roman Pfister; Stephan von Haehling; Lorenz H Lehmann; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2020-05-13       Impact factor: 5.460

3.  Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer.

Authors:  Ariane V S Macedo; Ludhmila A Hajjar; Alexander R Lyon; Bruno R Nascimento; Alessandro Putzu; Lorenzo Rossi; Rafael B Costa; Giovanni Landoni; Angélica Nogueira-Rodrigues; Antonio L P Ribeiro
Journal:  JACC CardioOncol       Date:  2019-09-24

4.  Increased Cancer Prevalence in Peripartum Cardiomyopathy.

Authors:  Tobias J Pfeffer; Stella Schlothauer; Stefan Pietzsch; Maria Schaufelberger; Bernd Auber; Melanie Ricke-Hoch; Manuel List; Dominik Berliner; Valeska Abou Moulig; Tobias König; Zolt Arany; Karen Sliwa; Johann Bauersachs; Denise Hilfiker-Kleiner
Journal:  JACC CardioOncol       Date:  2019-12-17

5.  Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects.

Authors:  Melanie Ricke-Hoch; Denise Hilfiker-Kleiner; Stefan Pietzsch; Katharina Wohlan; James T Thackeray; Maren Heimerl; Sven Schuchardt; Michaela Scherr
Journal:  Basic Res Cardiol       Date:  2021-10-20       Impact factor: 17.165

Review 6.  High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity.

Authors:  George E G Kluck; Kristina K Durham; Jeong-Ah Yoo; Bernardo L Trigatti
Journal:  Front Cardiovasc Med       Date:  2020-04-28

Review 7.  Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?

Authors:  Alessandra Murabito; Emilio Hirsch; Alessandra Ghigo
Journal:  Front Cardiovasc Med       Date:  2020-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.